title: [Systolic heart failure. New drug improves prognosis significantly].
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000613:Aminobutyrates / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D004338:Drug Combinations; D057239:Early Termination of Clinical Trials; D004656:Enalapril / Q000627:therapeutic use; D054143:Heart Failure, Systolic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000627:therapeutic use*; D000068756:Valsartan
chemical_list: D000613:Aminobutyrates; D057911:Angiotensin Receptor Antagonists; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D004656:Enalapril; D000068756:Valsartan; C549068:sacubitril and valsartan sodium hydrate drug combination